178 related articles for article (PubMed ID: 15618168)
1. Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.
Walters N; Trunkle T; Sura M; Pascual DW
Infect Immun; 2005 Jan; 73(1):317-24. PubMed ID: 15618168
[TBL] [Abstract][Full Text] [Related]
2. Fimbriated Salmonella enterica serovar typhimurium abates initial inflammatory responses by macrophages.
Pascual DW; Trunkle T; Sura J
Infect Immun; 2002 Aug; 70(8):4273-81. PubMed ID: 12117936
[TBL] [Abstract][Full Text] [Related]
3. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.
Pascual DW; White MD; Larson T; Walters N
J Immunol; 2001 Jul; 167(1):407-15. PubMed ID: 11418677
[TBL] [Abstract][Full Text] [Related]
4. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
5. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.
Ascón MA; Hone DM; Walters N; Pascual DW
Infect Immun; 1998 Nov; 66(11):5470-6. PubMed ID: 9784559
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate.
Kodama C; Eguchi M; Sekiya Y; Yamamoto T; Kikuchi Y; Matsui H
Microbiol Immunol; 2005; 49(12):1035-45. PubMed ID: 16365528
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.
Hur J; Lee JH
Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
Łaniewski P; Baek CH; Roland KL; Curtiss R
mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
[No Abstract] [Full Text] [Related]
11. Role of B7 costimulatory molecules in mediating systemic and mucosal antibody responses to attenuated Salmonella enterica serovar Typhimurium and its cloned antigen.
Garcia CA; Martin M; Michalek SM
Infect Immun; 2004 Oct; 72(10):5824-31. PubMed ID: 15385483
[TBL] [Abstract][Full Text] [Related]
12. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
14. Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.
Sbrogio-Almeida ME; Mosca T; Massis LM; Abrahamsohn IA; Ferreira LC
Infect Immun; 2004 May; 72(5):2546-55. PubMed ID: 15102762
[TBL] [Abstract][Full Text] [Related]
15. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.
Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T
Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli.
Yang X; Thornburg T; Holderness K; Suo Z; Cao L; Lim T; Avci R; Pascual DW
J Biomed Biotechnol; 2011; 2011():632396. PubMed ID: 22007145
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.
Zhao Z; Xue Y; Wu B; Tang X; Hu R; Xu Y; Guo A; Chen H
Infect Immun; 2008 May; 76(5):2157-63. PubMed ID: 18268026
[TBL] [Abstract][Full Text] [Related]
19. Protective Immunity Elicited by Oral Immunization of Mice with
Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.
Okahashi N; Yamamoto M; Vancott JL; Chatfield SN; Roberts M; Bluethmann H; Hiroi T; Kiyono H; McGhee JR
Infect Immun; 1996 May; 64(5):1516-25. PubMed ID: 8613355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
